These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28118356)

  • 1. Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.
    Medeiros NI; Fares RC; Franco EP; Sousa GR; Mattos RT; Chaves AT; Nunes MD; Dutra WO; Correa-Oliveira R; Rocha MO; Gomes JA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005284. PubMed ID: 28118356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Different IL-1β Activation Pathways in Innate Immune Cells From Indeterminate and Cardiac Patients With Chronic Chagas Disease.
    Medeiros NI; Pinto BF; Elói-Santos SM; Teixeira-Carvalho A; Magalhães LMD; Dutra WO; Correa-Oliveira R; Gomes JAS
    Front Immunol; 2019; 10():800. PubMed ID: 31057540
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.
    Gomes JA; Campi-Azevedo AC; Teixeira-Carvalho A; Silveira-Lemos D; Vitelli-Avelar D; Sathler-Avelar R; Peruhype-Magalhães V; Silvestre KF; Batista MA; Schachnik NC; Correa-Oliveira R; Eloi-Santos S; Martins-Filho OA
    Immunobiology; 2012 Oct; 217(10):1005-16. PubMed ID: 22387073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.
    Gomes JA; Molica AM; Keesen TS; Morato MJ; de Araujo FF; Fares RC; Fiuza JA; Chaves AT; Pinheiro V; Nunes Mdo C; Correa-Oliveira R; da Costa Rocha MO
    Hum Immunol; 2014 Jan; 75(1):20-8. PubMed ID: 24071371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
    Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
    Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergic and antagonistic relationship between MMP-2 and MMP-9 with fibrosis and inflammation in Chagas' cardiomyopathy.
    Medeiros NI; Gomes JAS; Correa-Oliveira R
    Parasite Immunol; 2017 Aug; 39(8):. PubMed ID: 28543409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.
    Fares RC; Gomes Jde A; Garzoni LR; Waghabi MC; Saraiva RM; Medeiros NI; Oliveira-Prado R; Sangenis LH; Chambela Mda C; de Araújo FF; Teixeira-Carvalho A; Damásio MP; Valente VA; Ferreira KS; Sousa GR; Rocha MO; Correa-Oliveira R
    Infect Immun; 2013 Oct; 81(10):3600-8. PubMed ID: 23856618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
    Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of MMP-9 and inflammatory cytokines by Trypanosoma cruzi-infected macrophages.
    de Pinho RT; da Silva WS; de Castro Côrtes LM; da Silva Vasconcelos Sousa P; de Araujo Soares RO; Alves CR
    Exp Parasitol; 2014 Dec; 147():72-80. PubMed ID: 25448360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific activation of CD4
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Nunes MDCP; Gollob KJ; Dutra WO
    Clin Exp Immunol; 2017 Oct; 190(1):122-132. PubMed ID: 28543170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
    Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
    BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients.
    Damasio MPS; Rocha MOC; Sousa GR; Ferreira KS; Fares-Gusmão RCG; Medeiros NI; Araujo FF; Chaves AT; Dutra WO; Correa-Oliveira R; Gomes JAS
    Hum Immunol; 2019 Jul; 80(7):517-522. PubMed ID: 30853363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.
    Souza PE; Rocha MO; Rocha-Vieira E; Menezes CA; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2004 Sep; 72(9):5283-91. PubMed ID: 15322024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cytokine expression is associated with cardiac morbidity in chagas disease.
    Sousa GR; Gomes JA; Fares RC; Damásio MP; Chaves AT; Ferreira KS; Nunes MC; Medeiros NI; Valente VA; Corrêa-Oliveira R; Rocha MO
    PLoS One; 2014; 9(3):e87082. PubMed ID: 24603474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.
    Pinto BF; Medeiros NI; Teixeira-Carvalho A; Eloi-Santos SM; Fontes-Cal TCM; Rocha DA; Dutra WO; Correa-Oliveira R; Gomes JAS
    Front Immunol; 2018; 9():454. PubMed ID: 29599775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients.
    Gomes JA; Bahia-Oliveira LM; Rocha MO; Busek SC; Teixeira MM; Silva JS; Correa-Oliveira R
    Infect Immun; 2005 Dec; 73(12):7960-6. PubMed ID: 16299288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems Biology Reveals Relevant Gaps in Fc-γR Expression, Impaired Regulatory Cytokine Microenvironment Interfaced With Anti-
    Gomes JAS; de Araújo FF; Vitelli-Avelar DM; Sathler-Avelar R; Lage PS; Wendling APB; do Vale INPC; Dias JCP; Elói-Santos SM; Teixeira-Carvalho A; Martins-Filho OA
    Front Microbiol; 2018; 9():1608. PubMed ID: 30105007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.